Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
11 Mar 2019 10:38 AM
RNS
Axovant's update on Phase 2 trial of AXO-Lenti-PD
01 Mar 2019 09:30 AM
RNS
Total Voting Rights
25 Feb 2019 12:23 PM
RNS
Director Dealings / Market Share Purchase
08 Feb 2019 07:00 AM
RNS
Notice of Results
07 Feb 2019 11:49 AM
RNS
Director/PDMR Shareholding
07 Feb 2019 09:22 AM
RNS
Update on programmes outlicensed to Sanofi
06 Feb 2019 11:00 AM
RNS
Director Dealings / Market Share Transactions
05 Feb 2019 10:22 AM
RNS
Director Dealings / Market Share Purchase
01 Feb 2019 10:00 AM
RNS
Total Voting Rights
24 Jan 2019 11:20 AM
RNS
Director Dealings / Market Share Purchase
18 Jan 2019 10:51 AM
RNS
Director Dealings / Market Share Purchase
03 Jan 2019 12:20 PM
RNS
Block listing Interim Review
02 Jan 2019 10:17 AM
RNS
Total Voting Rights
21 Dec 2018 01:16 PM
RNS
Director Dealings / Market Share Purchase
06 Dec 2018 04:11 PM
RNS
Axovant FDA meeting feedback
03 Dec 2018 09:53 AM
RNS
Total Voting Rights
03 Dec 2018 07:00 AM
RNS
Longer term Kymriah efficacy and safety data
23 Nov 2018 10:41 AM
RNS
Director Dealings
23 Nov 2018 07:00 AM
RNS
Oxford Biomedica form digital framework initiative
09 Nov 2018 07:00 AM
RNS
Block listing application
01 Nov 2018 02:41 PM
RNS
Total Voting Rights
25 Oct 2018 07:00 AM
RNS
Axovant Doses First Patient with AXO-Lenti-PD
22 Oct 2018 04:39 PM
RNS
Director Dealings / Market Share Purchase
05 Oct 2018 07:00 AM
RNS
Details of alliance with Orchard Therapeutics
01 Oct 2018 09:41 AM
RNS
Total Voting Rights
24 Sep 2018 12:20 PM
RNS
Director/PDMR Shareholding
20 Sep 2018 10:55 AM
EQS
Oxford BioMedica (OXB): Partnering strategy del...
13 Sep 2018 07:00 AM
RNS
Oxford BioMedica Interim Results
13 Sep 2018 07:00 AM
RNS
Oxford BioMedica further capacity expansion
03 Sep 2018 09:18 AM
RNS
Total Voting Rights
28 Aug 2018 07:00 AM
RNS
Kymriah® receives European Commission Approval
22 Aug 2018 11:58 AM
RNS
Director/PDMR Shareholding
15 Aug 2018 07:00 AM
RNS
RNS notice of results OXB
14 Aug 2018 07:15 AM
EQS
Oxford BioMedica (OXB): Risk-sharing in cystic ...
13 Aug 2018 10:55 AM
RNS
Director/PDMR Shareholding
13 Aug 2018 10:48 AM
RNS
Director/PDMR Shareholding
10 Aug 2018 11:39 AM
RNS
PDMR Dealings / Market Share Sale
10 Aug 2018 11:36 AM
RNS
Director Dealings / Market Share Sale and Purchase
08 Aug 2018 02:45 PM
RNS
Share Options and LTIPs Granted
06 Aug 2018 07:02 AM
RNS
Partnership for Cystic Fibrosis Gene Therapy
01 Aug 2018 09:53 AM
RNS
Total Voting Rights
23 Jul 2018 12:54 PM
RNS
Director Dealings / Market Share Purchase
02 Jul 2018 10:25 AM
RNS
Directorate Change
02 Jul 2018 09:47 AM
RNS
Total Voting Rights
29 Jun 2018 01:37 PM
RNS
Kymriah receives positive CHMP opinion
25 Jun 2018 05:19 PM
RNS
Holdings in Company
22 Jun 2018 12:05 PM
RNS
Confirmation of change of Auditor
22 Jun 2018 12:03 PM
RNS
Director Dealings / Market Share Purchase
21 Jun 2018 05:52 PM
RNS
Holdings in Company
14 Jun 2018 09:50 AM
EQS
Oxford BioMedica (OXB): Gene-therapy for Parkin...
UK 100